CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER. (2022). World Bulletin of Social Sciences, 7, 1-4. https://scholarexpress.net/index.php/wbss/article/view/514